Status:
RECRUITING
AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study
Lead Sponsor:
Radiometer Medical ApS
Conditions:
Diagnostic Tests
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to establish the correlation between sample matrices, and to determine the sample stability for the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.
Eligibility Criteria
Inclusion
- Subjects must be able to understand given information and demonstrate willingness and ability to voluntarily give a signed, valid written informed consent to participate in the study.
- Subjects must be 18 years of age or older.
- Subjects with expected NT-proBNP concentrations within the measuring range of NTproBNP2 Test Kit.
Exclusion
- Subjects known to be pregnant or breast-feeding.
- Subjects previously enrolled in the study.
- Subject, who has withdrawn consent.
Key Trial Info
Start Date :
May 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06905392
Start Date
May 15 2025
End Date
December 1 2025
Last Update
December 18 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hennepin Healthcare (Research Institute/ Minneapolis Medical Research Foundation)
Minneapolis, Minnesota, United States, 55404
2
Hospital Universitario Virgen de la Arrixaca
Murcia, Spain
3
Clinica Universidad de Navarra
Pamplona, Spain, 31008
4
Hospital Clinico Universitario de Santiago Compostela
Santiago de Compostela, Spain